GlassScriptPhysician profile
Sehem Ghazala
NPI 1265846950
$1,567.83
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,080 · 2020: $93.96 · 2021: $155 · 2022: $42.94 · 2023: $146 · 2024: $49.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $195.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $465.12 | 2019-2023 | |
| Boston Scientific Corporation | $312.64 | 2019-2021 | |
| Gilead Sciences, INC. | $226.78 | 2019 | |
| Janssen Biotech, INC. | $180.16 | 2019-2020 | |
| Pentax of America, INC. | $96.29 | 2021-2023 | Inspira |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $63.88 | 2019 | |
| Shionogi INC | $45.35 | 2019 | |
| Pfizer INC. | $42.29 | 2023-2024 | |
| Shire North American Group INC | $35.64 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.48 | 2020 | |
| Phathom Pharmaceuticals, INC. | $26.63 | 2024 | Voquezna |
| Fujifilm Healthcare Americas Corporation | $21.34 | 2022 | |
| Olympus America INC. | $20.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sehem Ghazala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.